IT Services Revenue in Life Sciences to Reach $4.5B

Speed to market is the primary focus of biopharmaceutical and medical device firms when it comes to their investment in life sciences IT services (ITS), a market that is expected to grow at a steady 9% compound annual growth rate (CAGR) through 2025.

via Everest Group